Back to Results
First PageMeta Content
European Organisation for Research and Treatment of Cancer / Women physicians / Year of birth missing / Clinical research / Research / Françoise Meunier / Clinical trial / Medicine / Health / Cancer organizations


Protocol Development Process, Selection and Approval Procedures for EORTC Studies POL016 Version 3.1 ALWAYS REFER TO THE EORTC INTERNET WEBSITE TO CHECK THE VALIDITY OF THIS DOCUMENT
Add to Reading List

Document Date: 2014-04-22 07:51:17

Open Document

File Size: 163,84 KB

Share Result on Facebook

Company

Accounting Finance / EORTC Group / STUDY PROPOSAL A Group / HQ / /

Event

FDA Phase / Business Partnership / Person Communication and Meetings / /

Facility

EORTC Headquarters / EORTC HQ / COMPLIANCE TO MILESTONES AND TIMELINES EORTC HQ / /

IndustryTerm

pharmaceutical industry organization / resource estimations / them into full protocols / cooperative / INTERNET WEBSITE / pharmaceutical / /

Organization

Elderly Task Force / Translational Research Advisory Committee / EORTC mission / New Drug Advisory Committee / TRI Department / Academic Fund / EORTC Board / Protocol Review Committee / /

Person

Denis Lacombe / Martine Van Glabbeke / Vassilis Golfinopoulos / Françoise Meunier / /

Position

Statistician / driver / Study Coordinator for each proposed study / actor / DOCUMENT Author / Study Coordinator / the Group Chair / Study Coordinator / Executive / Chair / Chair the Group / Group Chair / and the HQ team / Clinical Research Physician / Head / Director General / change Author / Study Coordinator / Group Chair / Medical Vice Director / /

Product

Group / New Drug / POL016 / /

ProgrammingLanguage

TRAC / /

Technology

3.1 Protocol / drug development / /

SocialTag